Skip to main content

Advertisement

Log in

Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Cyclin D1 (CCND1) is a key regulatory protein, playing a critical role in the transition from G1 to S phase of the cell cycle. We have evaluated the association between CCND1 A870G polymorphism and risk of cervix cancer in north Indian women by using PCR–RFLP method. This association was estimated by computing odds ratio (ORs) and a 95% Confidence Intervals (95% CI) using a Multivariate Logistic Regression Analysis. No significant association was observed between CCND1 genotypes and overall risk of cervix cancer. But when stratified histologically, statistically significant (OR: 3.7, 95% CI: 1.56–8.87, P: 0.001) increased risk of squamous cell carcinoma (SCC) was observed for individuals with AA genotype. Thus our findings suggest that CCND1 (G870A) polymorphism may be associated with increased risk of SCC of the uterine cervix in north Indian women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Copper GM (ed) (1997) The cell: a molecular approach. Washington (DC), ASM Press, p 599

    Google Scholar 

  2. Devita VT, Hellman S, Rosenberg SA (eds) (1997) Cancer; principles and practice of oncology. Lippincott Raven New York, pp 121–129

  3. Sherr CJ (1996) Cancer cell cycles. Science 274:1672–1677. doi:10.1126/science.274.5293.1672

    Article  PubMed  CAS  Google Scholar 

  4. Sherr CJ (1995) D-type cyclins. Trends Biochem Sci 20:187–190. doi:10.1016/S0968-0004(00)89005-2

    Article  PubMed  CAS  Google Scholar 

  5. Matsushime H, Ewen ME, Strom DK et al (1992) Identification and properties of an atypical catalytic subunit (p34pSKJ3/CDK4) for mammalian D type G1 cyclins. Cell 71:323–334. doi:10.1016/0092-8674(92)90360-O

    Article  PubMed  CAS  Google Scholar 

  6. Kato J, Matsuoka M, Strom DK et al (1994) Regulation of cyclin dependent kinase 4 (cdk4) by csk 4-activating kinase. Mol Cell Biol 14:2713–2721

    PubMed  CAS  Google Scholar 

  7. Nevins JR (1992) E2F: a link between the Rb tumor suppressor protein and oncoproteins. Science 258:424–429. doi:10.1126/science.1411535

    Article  PubMed  CAS  Google Scholar 

  8. Maeda K, Chung YS, Kang SM et al (1998) Cyclin D1 over expression and prognosis in colorectal adenocarcinoma. Oncology 55:145–151. doi:10.1159/000011849

    Article  PubMed  Google Scholar 

  9. Marsh KL, Varley JM (1998) Frequent alternation of cell cycle regulators in early stage breast lesions as detected by immunohistochemistry. Br J Cancer 77:1460–1468

    PubMed  CAS  Google Scholar 

  10. Jares P, Fernandez PL, Camp E et al (1994) Cyclin D1 gene amplification correlated with messenger RNA over expression and tumor progression in human laryngeal carcinomas. Cancer 54:4813–4817

    CAS  Google Scholar 

  11. Shapiro GI, Edwards CD, Kobzik L et al (1995) Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer 55:505–509

    CAS  Google Scholar 

  12. Bae DS, Cho SB, Kim YJ et al (2001) Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 81:341–347. doi:10.1006/gyno.2001.6196

    Article  PubMed  CAS  Google Scholar 

  13. Nichols GE, Williams ME, Gaffey MJ et al (1996) Cyclin D1 gene expression in human cervical neoplasia. Mod Pathol 9:418–425

    PubMed  CAS  Google Scholar 

  14. Kurzock R, Ku S, Talpaz M (1995) Abnormalities in the PRAD1 (CYCLIN D1 BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer 75:584. doi:10.1002/1097-0142(19950115)75:2<584::AID-CNCR2820750223>3.0.CO;2-P

  15. Betticher DC, Thatcher N, Altermatt HJ et al (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11:1005–1011

    PubMed  CAS  Google Scholar 

  16. Hosokawa Y, Gadd M, Smith AP et al (1997) Cyclin D1 alternative transcript B full-length cDNA cloning and expression in breast cancers. Cancer Lett 113:123–130. doi:10.1016/S0304-3835(97)04605-3

    Article  PubMed  CAS  Google Scholar 

  17. Diehl JA, Zindy F, Sherr CJ (1997) Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via ubiquitin proteasome pathway. Genes Dev 11:957–972. doi:10.1101/gad.11.8.957

    Article  PubMed  CAS  Google Scholar 

  18. Diehl JA, Cheng M, Roussel MF et al (1998) Glycogen synthase kinase 3-beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499–13511. doi:10.1101/gad.12.22.3499

    Article  PubMed  CAS  Google Scholar 

  19. Alt JR, Cleveland JL, Hannink M et al (2000) Phosphorylation dependent regulation of cyclin D1 nuclear export and CD1 dependent cellular transformation. Genes Dev 14:3102–3114. doi:10.1101/gad.854900

    Article  PubMed  CAS  Google Scholar 

  20. Sawa H, Ohshima TA V, Kita H et al (1995) Alternatively spliced formed of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 11:1005–10011

    Google Scholar 

  21. Wang L, Habuchi T, Takatashi T et al (2002) Cyclin gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23:257–264. doi:10.1093/carcin/23.2.257

    Article  PubMed  Google Scholar 

  22. Zheng Y, Shen H, Sturgis EM et al (2001) Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case control study. Carcinogenesis 22:1195–1199. doi:10.1093/carcin/22.8.1195

    Article  PubMed  CAS  Google Scholar 

  23. Le Marchand L, Seifriend J, Lum-Jones L et al (2003) Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA 290:2843–2848. doi:10.1001/jama.290.21.2843

    Article  PubMed  CAS  Google Scholar 

  24. Roe BA, Crabtree JS, Khan AS (eds) (1995) Methods for DNA isolation. Part III. In: Protocols for recombinant DNA isolation, cloning, and sequencing. Norman, OK: University of Oklahoma. Available from http://www.genome.ou.edu/protocol_book/protocol_index.html III; also available in paper copy as: DNA isolation and sequencing, Wiley New York, 1996

  25. Ferlay J, Bray F, Pisani P et al (2004) GLOBOCAN 2002: cancer incidence. Mortality and prevalence worldwide. IARC cancer base no. 5, version 2.0. IARC Press, Lyon

  26. Winkelstein W Jr (1990) Smoking and cervical cancer—current status: a review. Am J Epidemiol 131:945–957

    PubMed  Google Scholar 

  27. Giulian AR, Sedjo RL, Roe DJ et al (2002) Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control 13:839–846. doi:10.1023/A:1020668232219

    Article  Google Scholar 

  28. Trimble CL, Genkinger JM, Burke AE et al (2005) Active and passive cigarette smoking and risk of cervical neoplasia. Obstet Gynecol 105:174–181

    PubMed  Google Scholar 

  29. Sobti RC, Kaur S, Kaur P et al (2006) Interaction of passive smoking with GST (GSTM1, GSTT1 and GSTP1) genotypes in the risk of cervix cancer in north Indian population. Cancer Genet Cytogenet 166:117–123. doi:10.1016/j.cancergencyto.2005.10.001

    Article  PubMed  CAS  Google Scholar 

  30. Sobue T (1990) Association of indoor air pollution and lifestyle with lung cancer in Osaka, Japan. Int J Epidemiol 19:562–566

    Google Scholar 

  31. Dietz A, Senneweld E, Maier H (1995) Indoor air pollution by emissions of fossil fuel single stoves: possibly a hitherto underrated risk factor in the development of carcinomas in the head and neck. Otolaryngol Head Neck Surg 112:308–315. doi:10.1016/S0194-5998(95)70254-7

    Article  PubMed  CAS  Google Scholar 

  32. Pintos J, Franco E, Kowalski LP et al (1998) Use of wood stoves and risk of cancers of the upper aero-digestive tract: a case-control study. Int J Epidemiol 27:936–940. doi:10.1093/ije/27.6.936

    Article  PubMed  CAS  Google Scholar 

  33. Ferrera A, Velema JP, Figueroa M (2000) Co-factors related to the casual relationship between human papillomavirus and invasive cervical cancer in Honduras. Int J Epidemiol 29:817–825. doi:10.1093/ije/29.5.817

    Article  PubMed  CAS  Google Scholar 

  34. Velema JP, Ferrera A, Figueroa M et al (2002) Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras. Int J Cancer 97:536–541. doi:10.1002/ijc.1622

    Article  PubMed  CAS  Google Scholar 

  35. Martin CE (1967) Marital and coital factors in cervical cancer. Am J Public Health 57:803–814

    Article  CAS  Google Scholar 

  36. Worth AJ, Boyes DA (1972) A case control study into the possible effects of birth control pills on pre-clinical carcinoma of the cervix. J Obstet Gynaecol Br Commonw 79:673–679

    PubMed  CAS  Google Scholar 

  37. Coker AL, Hurka BS, McCann MF et al (1992) Barrier methods of contraception and cervical intraepithelial neoplasia. Contraception 45:1–10. doi:10.1016/0010-7824(92)90136-H

    Article  PubMed  CAS  Google Scholar 

  38. Brinton LA, Fraument JF Jr(1986) Epidemiology of uterine cervical cancer. J Chronic Dis 39:1065. doi:10.1016/0021-9681(86)90139-6

    Article  Google Scholar 

  39. Brinton LA (1991) Oral contraceptives and cervical neoplasia. Contraception 43:581–595. doi:10.1016/0010-7824(91)90005-Z

    Article  PubMed  CAS  Google Scholar 

  40. Jeon YT, Kim JW, Song JH et al (2005) Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women. Cancer Lett 223:259–263. doi:10.1016/j.canlet.2004.12.024

    Article  PubMed  CAS  Google Scholar 

  41. Sobti RC, Kaur P, Kaur S et al (2006) Effects of cyclin D1(CCND1) polymorphism on susceptibility to lung cancer in north Indian population. Cancer Genet Cytogenet 170:108–114. doi:10.1016/j.cancergencyto.2006.05.017

    Article  PubMed  CAS  Google Scholar 

  42. Catarino R, Matos A, Pinto D et al (2005) Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism. Cancer Genet Cytogenet 160:49–54. doi:10.1016/j.cancergencyto.2004.11.017

    Article  PubMed  CAS  Google Scholar 

  43. Holley SL, Matthias C, Jahnke V et al (2005) Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol 41:156–160. doi:10.1016/j.oraloncology.2004.08.005

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank all the staff and the patients who took part in this study. The work was funded by Council for Scientific and Industrial Research, New Delhi, India.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kaur Satinder.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Satinder, K., Chander, S.R., Pushpinder, K. et al. Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population. Mol Cell Biochem 315, 151–157 (2008). https://doi.org/10.1007/s11010-008-9799-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-008-9799-0

Keywords

Navigation